DJIA 16,982.59 22.02 0.13%
NASDAQ 4,444.91 -4.66 -0.10%
S&P 500 1,978.91 0.57 0.03%
market minute promo

Supernus Pharmaceuticals (NASDAQ: SUPN)

8.97 0.03 (0.34%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SUPN $8.97 0.34%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $8.92
Previous Close $8.94
Daily Range $8.72 - $9.09
52-Week Range $5.84 - $11.47
Market Cap $377.2M
P/E Ratio -3.34
Dividend (Yield) $0.00 (0.0%)
Volume 331,064
Average Daily Volume 515,115
Current FY EPS -$0.79

Sector

Healthcare

Industry

Drugs

Supernus Pharmaceuticals (SUPN) Description

Supernus Pharmaceuticals Inc specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system or CNS diseases. Website: http://www.supernus.com/

News & Commentary Rss Feed

This Week in Biotech

An FDA approval, a mixed batch of clinical data, a welcome pipeline update, and an ongoing patent battle are this week's must-watch biotech stories.

Supernus Up on Non-Dilutive Royalty Deal - Analyst Blog

How Supernus Pharmaceuticals (SUPN) Stock Stands Out in a Strong Industry - Tale of the Tape

How Supernus Pharmaceuticals (SUPN) Stock Stands Out in a Strong Industry - Tale of the Tape

Milestone Payment for Supernus - Analyst Blog

Why I'm Long Supernus, A Small Specialty Pharma Company

Supernus Pharmaceuticals' (SUPN) CEO Jack Khattar on Q1 2014 Results - Earnings Call Transcript

Oversold Conditions For Supernus Pharmaceuticals (SUPN)

Commit To Buy Supernus Pharmaceuticals At $5, Earn 26% Using Options

Is Supernus Pharmaceuticals (SUPN) Stock a Solid Choice Right Now? - Tale of the Tape

4 Stocks Under $10 Making Big Moves

SUPN: 2013 Revenues Exceed Analyst & Company Expectations; Maintaining Positive Outlook

See More SUPN News...